# A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

> **NCT02820896** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 74 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO7105705

## Key facts

- **NCT ID:** NCT02820896
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-29
- **Primary completion:** 2017-06-26
- **Final completion:** 2017-06-26
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820896, "A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02820896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*